
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- About


DMD Digital Health Connections Group Inc (APTOF)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: APTOF (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $12.5
1 Year Target Price $12.5
1 | Strong Buy |
0 | Buy |
0 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 0% | Avg. Invested days 0 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 3.34M USD | Price to earnings Ratio - | 1Y Target Price 12.5 |
Price to earnings Ratio - | 1Y Target Price 12.5 | ||
Volume (30-day avg) 1 | Beta 1.02 | 52 Weeks Range 0.64 - 15.00 | Updated Date 08/15/2025 |
52 Weeks Range 0.64 - 15.00 | Updated Date 08/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -7.85 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -162.74% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 14013966 | Price to Sales(TTM) - |
Enterprise Value 14013966 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue 0.9 | Enterprise Value to EBITDA 0.05 | Shares Outstanding 2552430 | Shares Floating 2035664 |
Shares Outstanding 2552430 | Shares Floating 2035664 | ||
Percent Insiders 20.25 | Percent Institutions 6.79 |
Upturn AI SWOT
DMD Digital Health Connections Group Inc

Company Overview
History and Background
It is not possible to provide the specific history of DMD Digital Health Connections Group Inc as that information is not readily available. This company is not publicly traded and the requested information is not in general public circulation.
Core Business Areas
Leadership and Structure
It is not possible to provide the Leadership and Structure of DMD Digital Health Connections Group Inc as that information is not readily available. This company is not publicly traded and the requested information is not in general public circulation.
Top Products and Market Share
Key Offerings
Market Dynamics
Industry Overview
Because DMD Digital Health Connections Group Inc is not publicly traded or tracked, industry information cannot be included.
Positioning
Because DMD Digital Health Connections Group Inc is not publicly traded or tracked, position information cannot be included.
Total Addressable Market (TAM)
It is not possible to determine the TAM without more information regarding the products, business segment, and market reach of the company.
Upturn SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
Competitors and Market Share
Key Competitors
Competitive Landscape
Competitive landscape information is not publicly available.
Growth Trajectory and Initiatives
Historical Growth: Growth information for this company is not publicly available.
Future Projections: Growth information for this company is not publicly available.
Recent Initiatives: Information on recent initiatives for this company is not publicly available.
Summary
DMD Digital Health Connections Group Inc's financial information is not readily available since it is not publicly traded. Therefore, a comprehensive analysis is not possible. Determining the company's strengths, weaknesses, opportunities, and threats (SWOT analysis) and future prospects is not possible without this data. To perform a proper assessment, proprietary financial data would need to be obtained.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Unable to obtain data for requested company
Disclaimers:
The information provided is based on the limited data available. No opinion on investment worthiness is provided as the data set is incomplete. Always conduct thorough research and seek professional advice before making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About DMD Digital Health Connections Group Inc
Exchange NASDAQ | Headquaters Toronto, ON, Canada | ||
IPO Launch date 2014-10-23 | Chairman, President & CEO Dr. William G. Rice Ph.D. | ||
Sector Healthcare | Industry Biotechnology | Full time employees 13 | Website https://www.aptose.com |
Full time employees 13 | Website https://www.aptose.com |
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops precision medicines addressing unmet medical needs in oncology primarily in the United States. The company's clinical-stage oral kinase inhibitors include tuspetinib (HM43239), a once-daily oral kinase inhibitor that has completed Phase 1/2 clinical trial targeting a select group of kinases operative in myeloid malignancies, such as acute myeloid leukemia and the higher risk myelodysplastic syndromes; and luxeptinib (CG-806), a potent oral small molecule, which is in Phase 1 a/b clinical trial in patients with relapsed or refractory B cell malignancies, including chronic lymphocytic leukemia, and certain non-Hodgkin's lymphomas, as well as relapsed or refractory acute myeloid leukemia. It has license agreements with CrystalGenomics Invites Co. Ltd. to research, develop, and commercialize luxeptinib; with National Cancer Institute for the clinical development of tuspetinib; and Hanmi Pharmaceutical Co Ltd. to research, develop, and commercialize tuspetinib. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.